Researchers see promise in treatment for autism symptoms

04/26/2012 | Disability Scoop

A drug compound known as GRN-529 is showing promise for the treatment of repetitive behaviors and socialization, considered to be two major facets of autism, researchers say. "Our findings suggest a strategy for developing a single treatment that could target multiple diagnostic symptoms," said the National Institute of Mental Health's Jacqueline Crawley, who worked on the study that was published Wednesday in the journal Science Translational Medicine.

View Full Article in:

Disability Scoop

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Partner - Strategy, Systems and Policy
Nationwide, SL_Nationwide
Professional Development Manager (West Coast residence preferred)
Rowland Reading Foundation
Nationwide, SL_Nationwide
Deputy Director for Curriculum, Instruction & Assessment
Department of Defense Education Activity (DoDEA)
School District of Philadelphia - Director, Observation and Feedback Coaches Program
School District of Philadelphia
Philadelphia, PA
Research Scientist
Portland, OR